Literature DB >> 4361676

Adenosine-mediated elevation of cyclic 3':5'-adenosine monophosphate concentrations in cultured mouse neuroblastoma cells.

A J Blume, C Dalton, H Sheppard.   

Abstract

Adenosine causes an increase in the concentration of cyclic AMP in mouse neuroblastoma cells. The amount of increase observed in intracellular cyclic AMP levels due to exogenous adenosine depends greatly on the concentration of a specific cyclic AMP phosphodiesterase inhibitor, 4-(-3-butoxy-4-methoxybenzyl)-2-imidazolidinone. Unstimulated concentrations of cyclic AMP were 29-40 pmol/mg of protein, and concentrations after addition of 0.2 mM adenosine were usually twice as high. The presence of 0.7 mM inhibitor along with 0.2 mM adenosine caused an increase in cyclic AMP levels up to 1000-2000 pmol/mg of protein. In the presence of 0.7 mM inhibitor, 2 muM adenosine gives a half-maximal cyclic AMP elevation. Theophylline blocked the elevation of cyclic AMP concentrations caused by exogenous adenosine. The data show that the cyclic AMP system of mouse neuroblastoma has the necessary receptor components to respond positively to exogenous adenosine. The results presented support a direct effect of adenosine, mediated through its control of intracellular levels, on neuronal elements of the nervous system.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4361676      PMCID: PMC427178          DOI: 10.1073/pnas.70.11.3099

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Cyclic AMP levels in fibroblasts: relationship to growth rate and contact inhibition of growth.

Authors:  J Otten; G S Johnson; I Pastan
Journal:  Biochem Biophys Res Commun       Date:  1971-09       Impact factor: 3.575

2.  Different sensitivities of the phosphodiesterases (adenosine-3',5'-cyclic phosphate 3'-phosphohydrolase) of dog cerebral cortex and erythrocytes to inhibition by synthetic agents and cold.

Authors:  H Sheppard; G Wiggan
Journal:  Biochem Pharmacol       Date:  1971-08       Impact factor: 5.858

3.  Regulation of adenosine 3',5'-cyclic monophosphate metabolism in cultured neuroblastoma cells.

Authors:  A G Gilman; M Nirenberg
Journal:  Nature       Date:  1971-12-10       Impact factor: 49.962

4.  Effect of catecholamines on the adenosine 3':5'-cyclic monophosphate concentrations of clonal satellite cells of neurons.

Authors:  A G Gilman; M Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1971-09       Impact factor: 11.205

5.  The effect of electrical stimulation upon the accumulation of adenosine 3',5'-phosphate in isolated cerebral tissue.

Authors:  S Kakiuchi; T W Rall; H McIlwain
Journal:  J Neurochem       Date:  1969-04       Impact factor: 5.372

6.  Analogues of 4-(3,4-dimethoxybenzyl)-2-imidazolidinone as potent inhibitors of rat erythrocyte adenosine cyclic 3',5'-phosphate phosphodiesterase.

Authors:  H Sheppard; G Wiggan
Journal:  Mol Pharmacol       Date:  1971-01       Impact factor: 4.436

7.  Radioimmunoassay for the measurement of adenosine 3',5'-cyclic phosphate.

Authors:  A L Steiner; D M Kipnis; R Utiger; C Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

8.  Neurotransmitter synthesis by neuroblastoma clones (neuroblast differentiation-cell culture-choline acetyltransferase-acetylcholinesterase-tyrosine hydroxylase-axons-dendrites).

Authors:  T Amano; E Richelson; M Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

9.  Stimulated formation of adenosine 3',5'-cyclic phosphate in cerebral cortex: synergism between electrical activity and biogenic amines.

Authors:  H Shimizu; C R Creveling; J Daly
Journal:  Proc Natl Acad Sci U S A       Date:  1970-04       Impact factor: 11.205

10.  Regulation of adenosine 3':5'-cyclic monophosphate concentration in cultured human astrocytoma cells by catecholamines and histamine.

Authors:  R B Clark; J P Perkins
Journal:  Proc Natl Acad Sci U S A       Date:  1971-11       Impact factor: 11.205

View more
  18 in total

1.  Influence of cyclic AMP and serum factors upon expression of a retinoid-responsive gene in neuroblastoma cells.

Authors:  A K Hall
Journal:  J Mol Neurosci       Date:  1992       Impact factor: 3.444

Review 2.  Regulation of adenylate cyclase by adenosine.

Authors:  J N Fain; C C Malbon
Journal:  Mol Cell Biochem       Date:  1979-06-15       Impact factor: 3.396

3.  Two distinct adenosine-sensitive sites on adenylate cyclase.

Authors:  C Londos; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

4.  Endothelium-mediated coronary dilatation by adenosine does not depend on endothelial adenylate cyclase activation: studies in isolated guinea pig hearts.

Authors:  W H Newman; B F Becker; M Heier; S Nees; E Gerlach
Journal:  Pflugers Arch       Date:  1988-11       Impact factor: 3.657

5.  Functional evidence for the presence of adenosine A2-receptors in cultured coronary endothelial cells.

Authors:  C Des Rosiers; S Nees
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

6.  Characterization of adenosine receptors in rat brain by (-)[3H]N6-phenylisopropyladenosine.

Authors:  U Schwabe; T Trost
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

7.  Specific binding of 3H-adenosine to rat brain membranes.

Authors:  U Schwabe; H Kiffe; C Puchstein; T Trost
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

8.  Blockade of striatal neurone responses to morphine by aminophylline: evidence for adenosine mediation of opiate action.

Authors:  M N Perkins; T W Stone
Journal:  Br J Pharmacol       Date:  1980-05       Impact factor: 8.739

9.  Effects of the aminonucleoside of puromycin on glomerular epithelial cells in vitro.

Authors:  J A Fishman; M J Karnovsky
Journal:  Am J Pathol       Date:  1985-03       Impact factor: 4.307

10.  Adenosine inhibition of gamma-aminobutyric acid release from slices of rat cerebral cortex.

Authors:  C Hollins; T W Stone
Journal:  Br J Pharmacol       Date:  1980-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.